News
StockStory.org on MSN1d
Q1 Earnings Roundup: Herc (NYSE:HRI) And The Rest Of The Specialty Equipment Distributors SegmentLooking back on specialty equipment distributors stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...
Like any other new technological trend, robotic mowers prompt questions from potential adopters, and some specific, ...
BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...
Major players including AbbVie, GSK, Sanofi, and Eli Lilly recently bolstered their R&D pipelines with a wave of acquisitions ...
Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...
Asad Haider, head of the healthcare business unit within Goldman Sachs Research, now forecasts the market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, to ...
Detailed price information for Bank of Montreal (BMO-N) from The Globe and Mail including charting and trades.
Eli Lilly and Company and SiteOne Therapeutics, Inc., a private biotechnology company developing small molecule inhibitors of ...
SiteOne Landscape Supply is the nation's largest supplier of wholesale irrigation, outdoor lighting, nursery, landscape supplies, fertilizers, turf protection products, grass seed, turf care equipment ...
13d
Dealbreaker on MSNEli Lilly Pays $1 Billion For Non-Opioid Pain Med MakerEli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
Pharmaceutical company Eli Lilly has announced plans to acquire private biotech company SiteOne in a deal worth up to $1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results